martes, 16 de junio de 2015

EFPIA será "transparente" en 2016. "Disclosure Code" / Y mientras...?

The “eyes of the world will be upon the industry” from next year as payments to doctors in Europe becomes mandatory - and pharma must embrace this change to help improve the poor public perception of this relationship. 

This is according to David Morrow, head of medical excellence at AstraZeneca UK, who was speaking at the CompliMed Compliance Conference in London. 

The conference was being held before new rules in Europe will from July 2016 mandate that all members of the EU pharma trade group EFPIA disclose the name of every doctor and healthcare organisation with which they worked, listing the amounts paid to each in consultancy, travel, training and other fees. 

Morrow said: “The eyes of the world will be upon us in 2016, and we must be aware of the negative perception from the media over these types of payments.

Publicar un comentario